MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 94 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $20,000 | +33.3% | 10,000 | 0.0% | 0.01% | +40.0% |
Q3 2019 | $15,000 | -11.8% | 10,000 | +150.0% | 0.01% | -16.7% |
Q1 2019 | $17,000 | +54.5% | 4,000 | 0.0% | 0.01% | +50.0% |
Q4 2018 | $11,000 | -57.7% | 4,000 | +33.3% | 0.00% | -63.6% |
Q3 2018 | $26,000 | +85.7% | 3,000 | +50.0% | 0.01% | +83.3% |
Q2 2018 | $14,000 | -41.7% | 2,000 | -66.7% | 0.01% | -40.0% |
Q1 2018 | $24,000 | – | 6,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 1,340,588 | $1,354,000 | 0.34% |
BOOTHBAY FUND MANAGEMENT, LLC | 78,662 | $79,000 | 0.02% |
Orbimed Advisors | 567,600 | $573,000 | 0.01% |
Acrospire Investment Management LLC | 14,323 | $14,000 | 0.01% |
SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 10,000 | $10,000 | 0.00% |
Virtu KCG Holdings LLC | 49,847 | $50,000 | 0.00% |
NEXT Financial Group, Inc | 2,670 | $3,000,000 | 0.00% |
Squarepoint Ops LLC | 13,000 | $13,000 | 0.00% |
FRANKLIN RESOURCES INC | 2,182,185 | $2,204,000 | 0.00% |
A.R.T. Advisors, LLC | 16,830 | $16,000 | 0.00% |